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Abstract
Non-coding CUG repeat expansions interfere with the activity of human Muscleblind-like (MBNL) proteins contributing to
myotonic dystrophy 1 (DM1). To understand this toxic RNA gain-of-function mechanism we developed a Drosophila model
expressing 60 pure and 480 interrupted CUG repeats in the context of a non-translatable RNA. These flies reproduced
aspects of the DM1 pathology, most notably nuclear accumulation of CUG transcripts, muscle degeneration, splicing
misregulation, and diminished Muscleblind function in vivo. Reduced Muscleblind activity was evident from the sensitivity of
CUG-induced phenotypes to a decrease in muscleblind genetic dosage and rescue by MBNL1 expression, and further
supported by the co-localization of Muscleblind and CUG repeat RNA in ribonuclear foci. Targeted expression of CUG
repeats to the developing eye and brain mushroom bodies was toxic leading to rough eyes and semilethality, respectively.
These phenotypes were utilized to identify genetic and chemical modifiers of the CUG-induced toxicity. 15 genetic
modifiers of the rough eye phenotype were isolated. These genes identify putative cellular processes unknown to be altered
by CUG repeat RNA, and they include mRNA export factor Aly, apoptosis inhibitor Thread, chromatin remodelling factor
Nurf-38, and extracellular matrix structural component Viking. Ten chemical compounds suppressed the semilethal
phenotype. These compounds significantly improved viability of CUG expressing flies and included non-steroidal anti-
inflammatory agents (ketoprofen), muscarinic, cholinergic and histamine receptor inhibitors (orphenadrine), and drugs that
can affect sodium and calcium metabolism such as clenbuterol and spironolactone. These findings provide new insights
into the DM1 phenotype, and suggest novel candidates for DM1 treatments.
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Introduction
Myotonic dystrophy 1 (DM1) is an autosomal dominant
neuromuscular disease involving the expansion of unstable CTG
repeats in the 39 untranslated region (UTR) of the DM protein kinase
(DMPK) gene. DM1 is multisystemic and characteristic features
include myotonia, muscular dystrophy, iridescent cataracts, cardiac
arrhythmias, and signs of neuropathology [1]. A biochemical
hallmark of DM1 is misregulated alternative splicing of specific
skeletal muscle, heart and brain pre-mRNAs, which explain defined
DM1 symptoms such as myotonia (reviewed in [2]).
In mice, expression of 250 CUG repeats within a heterologous
RNA gives rise to DM1-like phenotypes thus demonstrating that
expanded CUG repeat transcripts are themselves toxic to cells [3].
Results in Drosophila, however, are less clear cut. Expression of 162
pure CTG repeats in the context of the 39UTR of a Green
Fluorescent Protein (GFP) reporter gene has been reported not to
cause signs of pathology [4] whereas larger, interrupted, CTG
repeats induced muscle degeneration [5]. Several RNA binding
proteins, most notably human Muscleblind-like proteins MBNL1,
MBNL2 andMBNL3, are sequestered by mutantDMPK transcripts.
MBNL1 proteins co-localize with distinctive CUG ribonuclear foci
within muscle and neuron nuclei in DM1 patients [6–8]. Drosophila
model flies, though, demonstrate that ribonuclear foci are not
pathogenic per se. RNA containing 162 CUG repeats accumulates in
numerous nuclear foci together with Drosophila Muscleblind, but no
evident pathogenic phenotype is detected [4]. DM1-associated
defects are remarkably similar to those observed in Mbnl1 knockout
mice and include myotonia, ocular cataracts, histological abnormal-
ities, and the abnormal use of specific alternative exons [9], [10].
muscleblind (mbl) loss-of-function mutations in Drosophila provide
additional examples of DM1-like phenotypes such as missplicing of
the Z-band-associated transcripts a-actinin and CG30084 [11], [12].
Mbnl1 regulates a fetal to postnatal developmental switch that
controls the splicing pattern of a set of murine skeletal muscle
transcripts [10]. CUG-binding protein 1 (CUG-BP1) forms an
RNA-dependent complex with hnRNP H that antagonizes the
activity of MBNL1 proteins [13]. Both CUG-BP1 and hnRNP H
are upregulated in DM1 muscle cells [13], [14] thus further
contributing to the splicing pathology. Significantly, rescue
experiments in DM1 model mice demonstrate that loss of Mbnl1
function is the key event of missplicing and myotonia [15].
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Additionally, overexpression of normal DMPK 39UTR mRNA in
mice induced up-regulation of CUG-BP1 and also reproduced
cardinal features of DM1 [16].
Great effort has been put to ameliorate myotonia and abnormal
cardiac conduction in DM1, which are currently treated with
sodium channel inhibitors (e.g. mexiletine). Muscular weakness
and wasting, or daytime somnolence, however, show little or no
improvement in pharmacological trials [17]. A number of
genotoxic agents suppress somatic CTG expansion mosaicism in
a cell culture model [18]. PC12 neuronal cell lines expressing 250
CTG repeats exhibit cell death after cell differentiation in vitro that
is specifically inhibited by flavonoids [19].
We previously established that DrosophilaMbl and humanMBNL1
proteins are functional homologs [20]. Haro et al. (2006) have
reported that expression of 480 interrupted CTG repeats is toxic to
Drosophila muscle cells, that CUG RNA and human MBNL1
accumulate into ribonuclear foci, and that human MBNL1
suppresses a CUG-induced eye phenotype. Here we describe similar
transgenic flies in which we confirmmuscle degeneration, ribonuclear
formation, and genetic interaction with muscleblind gene dosage. We
show that CUG expressing flies reproduce additional key features of
the DM1 disease including misregulated alternative splicing of muscle
genes, CUG tract length dependence of phenotypes, and CUG-
dependent central nervous system alterations. Furthermore, model
flies were used in genetic screens and functional assays to identify new
components of the pathogenesis pathway and chemical suppressors of
DM1-like phenotypes, respectively.
Results
Continued expression of expanded CUG repeats in
Drosophila reduces lifespan and causes muscle
degeneration
To understand the molecular and cellular mechanisms underlying
the DM1 pathology we generated transgenic Drosophila lines that
express 60 uninterrupted or 480 interrupted CUG repeats as a non-
coding transcript under the control of the Gal4/UAS system. 480
repeats consisted of synthetic CTG repeats interrupted every 20 units
by the CTCGA sequence (hereafter referred to as i(CTG)480).The
effect of expressing CUG repeat RNA in the Drosophila muscles or
ubiquitously in the fly was studied with Myosin heavy chain (Mhc)-Gal4
and daughterless (da)-Gal4 lines, respectively. First we analyzed
whether expression of i(CUG)480 RNA in Drosophila tissues had any
impact in their lifespan. Average survival of flies expressing
i(CUG)480 repeat RNA was lower than their corresponding control
flies heterozygous for the UAS transgene or Gal4 driver.
Furthermore, differences in survival curves were statistically
significant except for the Mhc-Gal4.UAS-i(CTG)480 and Mhc-Gal4/
+ survival curves, possibly due to a dominant effect of the Mhc-Gal4
insertion, as this is a particularly weak stock, or the small population
of flies tested (n=40) (Figure 1). Continued expression of CUG
repeat RNA in the fly musculature, or throughout the animal body,
was therefore detrimental to fly survival.
Flies expressing i(CUG)480 RNA in muscles additionally showed
an age-dependent tendency to position wings upheld. These flies
were flightless (n = 274) and showed alterations in indirect flight
muscles (IFM), whereas those expressing (CUG)60 RNA did not
(0% flightless, n = 204). Both UAS-(CTG)60 and UAS-i(CTG)480
transgenes expressed repeat RNA to similar levels (Figure S1A). 2–
3 day old flies expressing i(CUG)480 RNA developed muscle
histopathology, including vacuolization and reduction in fiber size
(Figure 2A–F). We measured cross-sectional area of dorso
longitudinal muscle 45e (Figure 2G). Average size of muscle 45e
decreased to approximately 45% of normal when expressing 480
CUG repeat transcripts. The phenotype was degenerative as 38-
day old flies had smaller IFM packages, muscles were occasionally
missing, and vacuoles increased in average volume (Figure 2H).
(CUG)60 RNA did not appreciably affect muscle organization.
Degeneration of the pigmentary retina and loss of photoreceptor
neurons has been described in DM1 patients [1]. To investigate
whether the retina of Drosophila was also susceptible to CUG repeat-
mediated toxicity, we expressed i(CUG)480 transcripts ubiquitously
in the eye-antennal imaginal disc under the control of the glass
multiple reporter (gmr)-Gal4 line. These flies showed eyes that were
smaller and acutely rough. Tangential and frontal sections revealed
severe alterations in the retina, including detachment of subretinal
cells, thinning of fenestrated membrane and lack of photoreceptor
rhabdomeres (Figure 2I–L). Expression of (CUG)60 RNA under the
same conditions did not appreciably affect eye morphology in tissue
sections (data not shown). Thus, accumulation of CUG repeat RNA
inDrosophilamuscle and eye tissue produces degenerative phenotypes
that are dependent on the CUG tract length.
CUG repeat RNA co-localizes with Muscleblind in nuclear
foci
Nuclear inclusions containing CUG repeats and MBNL proteins
are characteristic of DM1.We investigated whether i(CUG)480 RNA
similarly forms nuclear foci that include Drosophila Mbl. mbl encodes
protein isoforms MblA, B, C and D, of which MblC has been shown
Figure 1. Flies expressing CUG repeats show shorter lifespan. Average percentage of live flies, with the genotypes indicated, versus age (in
days). (A) Whereas control flies showed an average lifespan of 57 (UAS-i(CTG)480/+; n = 80) and 34 (Mhc-Gal4/+; n = 40) days, i(CUG)480-expressing flies
lived 13 days in average (n = 60). Differences in lifespan curves were highly significant when comparing i(CUG)480-expressing flies to UAS-i(CTG)480/+
control flies (p,0.0001, Log-Rank test) but not to Mhc-Gal4/+ controls. (B) Expression of i(CUG)480 transgene in an ubiquitous manner (da-Gal4.UAS-
i(CTG)480) also reduced fly survival. Control flies showed a median survival of 57 (UAS-i(CTG)480/+, n = 80) and 55 (da-Gal4/+, n = 40) days. Median
survival for i(CUG)480-expressing flies was of 41 days (n = 80), and lifespan curves for i(CUG)480-expressing flies and both controls showed differences
that were statistically significant (p,0.0001, Log-Rank test). Statistical analysis was performed using GraphPad Prism4 software.
doi:10.1371/journal.pone.0001595.g001
Toxicity Model in Drosophila
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to regulate alternative splicing [12]. We co-expressed i(CUG)480
RNA and the MblC isoform fused to the GFP (MblC:GFP) under
the control of a heat shock (hs)-Gal4 line. Simultaneous fluorescence
detection in fly thorax sections showed nuclear co-localization of
i(CUG)480 RNA andMblC (Figure 3A–C). This was not observed in
controls expressing i(CUG)480 RNA or the fusion protein alone.
(CUG)60 RNA did not form nuclear foci when targeted with Mhc-
Gal4 to adult musculature (data not shown). Therefore, Drosophila
MblC incorporates into expanded CUG repeat RNA-containing
foci like its human MBNL counterparts.
muscleblind dose modifies CUG toxicity phenotypes
sevenless (sev)-Gal4 driven expression of i(CUG)480 repeats (sev-
Gal4.UAS-i(CTG)480) disorganizes ommatidia and mechanosen-
sory bristles, and reduces eye size, which generates an externally
rough eye (Figure 3H). Introduction of the weak mbl7103 or strong
hypomorphic mblE27 mutant alleles in this genetic background did
not significantly modify eye morphology (Figure 3I, J; mblE27 may
reduce size slightly). However, a clear enhancement was observed
in mbl7103/mblE27 trans heterozygous flies simultaneously express-
ing i(CUG)480 RNA (Figure 3K). Conversely, targeted expression
of human MBNL1 to Drosophila eye precursors expressing 480
interrupted CUG repeat transcripts strongly suppressed the rough
eye phenotype, whereas expression of the unrelated GFP protein
under the same conditions showed no effect (Figure 3F, G). 60
CUG repeat RNA caused a milder effect on external eye
morphology, only altering mechanosensory bristles (Figure 3D,
E). From these experiments we conclude that CUG repeat RNA
compromises mbl function in vivo as similarly shown in DM1 model
mice and patients [21], [15], [10].
CUG repeat RNA induces spliceopathy in Drosophila
Sequestration of MBNL1 correlates with missplicing events in
DM1 patients. To assess whether long CUG repeat transcripts in
the fly produce analogous alterations, we studied the splicing
pattern of muscle genes CG30084, a described target of Mbl
activity in embryos [11], and Drosophila troponinT (TnT) in embryos,
pupae and adult flies expressing 60 CUG and 480 interrupted
CUG repeat RNAs (Figure 4). Missplicing of CG30084 pre-mRNA
was conspicuous with a strong upregulation of reverse transcrip-
tase (RT) PCR band E in adult flies expressing either 60 or 480
CUG repeat RNA (Figure 4A, C; see also Figure S2). TnT was
similarly affected. Two-day old pupae failed to show RT-PCR
band D, which was not expressed in younger pupae (data not
shown), when 480 interrupted CUG transcripts were targeted to
the musculature and significantly lowered its levels with 60 CUG
repeat RNA (Figure 4B, D). Thus, CUG transcripts induce
spliceopathy in the Drosophila musculature.
Figure 2. CUG-induced eye and muscle degeneration in flies. Transversal sections of resin-embedded (A–F) adult IFMs of control flies (Mhc-
Gal4/+) (A, D) and flies expressing (CUG)60 (B, E) or i(CUG)480 RNA (C, F) under the control of the Mhc-Gal4 driver. IFMs were studied in 2–3-day old (A–
C) or 38-day old (D–F) flies. Expression of (CUG)60 RNA was not toxic to muscle fibres (B), and IFMs did not degenerate over time (E). Expression of
i(CUG)480 RNA in IFMs led to vacuolization (arrowheads) and muscle disorganization (C). Muscle degeneration and wasting was conspicuous in 38-day
old flies with large vacuoles (arrowheads), lower density of myofibrils per muscle (arrow) and missing muscles (asterisk). Results consistent with these
have been obtained independently [5]. (G) Cross-sectional area of left dorso longitudinal muscle 45e [51] in 2 day-old control (Mhc-Gal4/+) and DM1
model flies (Mhc-Gal4.UAS-i(CTG)480). n = 12 (control) and n= 34 (CUG expressing). (H) Muscle degeneration was measured as the frequency of
vacuolar pathology and muscle area reduction, according to the following rating scale: vacuoles with diameter larger or smaller than 8 mm, or
showing 45% or less of the normal muscle area. Muscle 45e was measured in 3-4 thorax sections per animal and a total of 15 young (2-day-old) or 13
aged (38-day-old) flies were analyzed. Control (Mhc-Gal4/+) and Mhc-Gal4.UAS-(CTG)60 flies showed no muscle phenotype 2 or 38 days after
eclosion. Tangential (I, J) and frontal (K, L) sections of adult Drosophila eyes with the genotypes gmr-Gal4/+ (I, K) and gmr-Gal4/UAS-i(CUG)480 (J, L) at
25uC. (I) Tangential sections exhibited a normal complement of photoreceptors per ommatidial unit (arrowheads point to rhabdomeres), although
some pigment cells were absent. (J) Expression of expanded CUG repeats caused general disorganization of the eye retina. (K) In controls,
rhabdomeres extend from the apical to the basal side of the retina (arrowheads) and the layer of pigment cell feet forms the fenestrated membrane
(arrow), which is separated by the basement membrane (white arrowhead) from the underlying subretinal cells (bent arrow). (L) Eyes expressing
i(CUG)480 RNA lacked rhabdomeres and showed general disorganization of pigment cells. Fenestrated membranes were thinner and showed gaps
(arrow). Subretinal cells were not tightly apposed to the basement membrane (bent arrow).
doi:10.1371/journal.pone.0001595.g002
Toxicity Model in Drosophila
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Dominant genetic modifiers of a CUG-induced rough eye
phenotype
Once cardinal aspects of DM1 were confirmed in flies, we
sought to identify new components of the pathogenic pathway. We
performed a genetic screen of enhancer/suppressors of the sev-
Gal4.UAS-i(CTG)480 rough eye phenotype using a collection of
695 lethal P-element insertions and several candidate genes
(Table 1, Figure 5A–H).
Some modifiers are regulators of gene expression. The
suppressor cap-n-collar (cnc) encodes a bZIP protein involved in
oocyte axis determination and head segment identity [22], [23].
Three Cnc protein isoforms have been described, of which CncC
has been suggested to play a role in redox homeostasis [24]. We
tested the ability of alleles cnc03921 (disrupts all cnc isoforms),
cncEP3258 and cncEP3633 (interrupts cncC) to modify the CUG toxicity
phenotype. Only cnc03921 dominantly suppressed the eye pheno-
type thus suggesting a limited or null implication of CncC in CUG
toxicity. Halving the pyrophosphatase component of the Nucle-
osome remodelling factor (Nurf-38) improved eye morphology but
did not suppress unrelated overexpression phenotypes in the eye
(data not shown).
Additional modifiers identified genes and pathways not previously
implicated in CUG-induced toxicity. Mutations in the regulators of
cell adhesion and actin cytoskeleton coronin (coro) [25] and fear of
intimacy (foi) [26] suppressed the phenotype. Reduction of the major
structural component of basement membrane a2-chain type IV
collagen (vkgk00236) enhanced the sev-Gal4.UAS-i(CTG)480 phenotype.
Some modifiers of CUG toxicity control cell number. Csk
negatively regulates the Src family of cytoplasmic tyrosine kinases.
Mutations in Csk, which enlarge organs due to increased cell
proliferation [27], suppressed i(CUG)480 RNA toxicity (Csk
j1D8).
Mutations in the pro- and anti-cell death genes spinster and thread
were suppressors and enhancers, respectively. Drosophila inhibitor
of apoptosis protein (Diap), encoded by the thread (th) gene, showed
complex interactions. Of the three alleles tested, loss-of-function
th4 and th5 and gain-of-function th6-3s, only th4 strongly enhanced
the CUG toxicity phenotype (Figure 5F). Nevertheless, sev-Gal4
driven overexpression of th (thEP3308) in eyes simultaneously
expressing i(CUG)480 significantly suppressed the phenotype
(Figure 5G) whereas expression of a control GFP transgene
(UAS-GFP) under comparable conditions did not modify eye
morphology. A similar suppression was observed upon expression
Figure 3. Muscleblind forms nuclear inclusions with CUG repeat RNA and genetically interacts with repeat RNA phenotypes in vivo.
i(CUG)480 RNA and MblC:GFP were coexpressed in adult flies using a hs-Gal4 line (A–C). i(CUG)480 transcripts detected by FISH (red; A) and MblC:GFP
detected by the GFP tag (green; B). Red and green channels are shown merged in (C), with nuclei counterstained with DAPI. Scanning electron
microscope (SEM) images of Drosophila eyes (D–K). (D) External morphology of reference strain OrR. (E) sev-Gal4 driven expression of (CUG)60 RNA in
eye precursors exhibits mild external defects, only altering mechanosensory bristles. Expression of i(CUG)480 RNA driven by the same Gal4 generates a
rough and reduced eye (H), a phenotype that is specifically suppressed by the simultaneous expression of human MBNL1 (G) but not by expression of
the unrelated GFP protein (F). The CUG-dependent eye phenotype was not modified by the weak mbl7103 allele (I), and only slightly modified by
mblE27 (J). However, the compound heterozygote enhanced roughness and eye size reduction (K). The compound heterozygote mbl7103/mblE27
displayed normal eyes in the absence of i(CUG)480 RNA.
doi:10.1371/journal.pone.0001595.g003
Toxicity Model in Drosophila
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of the closely related Diap2 protein (gmr-diap2 fusion construct).
Furthermore, th4 and th5 dominantly enhanced mblC overexpres-
sion in the Drosophila eye [28].
The sev-Gal4.UAS-i(CTG)480 eye phenotype was enhanced by
halving the genetic dose of the mRNA export factor Aly. Several
observations indicate a close relationship between mRNA export
factors and exon junction complex (EJC) components [29].
However, when we tested a lethal mutation in EJC core
component tsunagi (tsuEP567) we found no effect. In summary we
identified four cellular processes likely altered by CUG repeat
RNA: gene transcription, cell adhesion, programmed cell death
and export of nuclear transcripts.
Targeted expression of expanded CUG repeats to the
mushroom bodies produces a temperature-sensitive
pupal lethal phenotype
Mushroom bodies (MBs) are brain structures involved in
learning, sleep and memory. Because of the central nervous
system involvement in DM1, we targeted expression of (CUG)60
Figure 4. CUG repeat RNA misregulates alternative splicing of muscle genes CG30084 and TnT. RT-PCR products from CG30084 (A) and
TnT (B) at the stages and from animals with the genotypes indicated. Bar graph representing intensities of ethidium bromide fluorescence (ranging
from 0 to 100%, which equalled saturation) of band E (CG30084; C) and band D (TnT; D) from the specified genotypes. All RT-PCRs were within the
linear range of amplification. Abbreviations used: 16–18 h after egg laying embryos (E); 2-day old pupae (P); 6–30 h after eclosion adults (A). All
missplicing events were detected at least twice from independent RNA extractions.
doi:10.1371/journal.pone.0001595.g004
Table 1. Genetic enhancers and suppressors of a CUG-dependent rough eye phenotype
Gene Description Line LOF/GOF alleles
cnc bZIP transcription factor l(3)j5E7 cnc03921 S
seven up orphan nuclear receptor - svp1, svp07842 E
Nurf-38 Nucleosome remodeling factor l(2)k16102 Nurf-38k16102 S
jumeau FKH/WH transcription/remodeling factor l(3)j8B6 jumu06439, jumuL70 S
foi zinc ion transporter l(3)j8E8 foij8E8, foineo13 S
viking alpha 2-chain type IV collagen l(2)k00236 vkgk00236 E
coro F-actin binding protein coronin l(2)k08011 coroex8 S
Csk negative regulator of Src protein family l(3)j1D8 Cskj1D8 S
spinster cell death-inducing transmembrane protein l(2)k09905 spink09905 S
thread inhibitor of apoptosis protein - thread4/thEP3308 E/S
Aly mRNA export factor - Aly02267 E
CG4589 putative calcium binding protein l(2)k10502 - E
- probably affects mAcR-60C or slik l(2)k00808 - S
- unknown l(2)k05911 - S
- unknown l(2)k09907 - E
Mutations assayed in the screen (Line). LOF/GOF column designates other loss (LOF) or gain-of-function (GOF) alleles showing interaction, or confirms that the line
assayed is a known allele of the indicated gene. svp1, thread4 and Aly02267 were tested as candidate interacting mutations. None of the modifiers exhibit dominant eye
phenotypes on their own. A second vkg loss-of-function allele (vkg01209) did not significantly modify eye morphology. Abbreviations: basic-leucine zipper (bZIP); fork
head winged-helix (FKH/WH); Suppressor (Su); Enhancer (En).
doi:10.1371/journal.pone.0001595.t001
Toxicity Model in Drosophila
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and i(CUG)480 RNA to the Drosophila MBs (Figure 5I). Expression
with the X-linked 103Y-Gal4 driver was not deleterious at 25uC.
However, an increase in the level of expression (by raising the
temperature) originated a female-specific semilethal phenotype in
F1 mature pupae expressing 480 interrupted CUG repeat RNA
(Figure 5A). 28uC offered a threshold to CUG toxicity since only
about 20% of emerged F1 individuals were females (versus 50%
expected) and some died during eclosion.
Reducing the genetic dose of mbl in a background expressing
CUG repeats in the MBs (103Y-Gal4/+; mblE27/+; UAS-
i(CTG)480/+) reduced the number of F1 females six fold compared
to control flies that expressed CUG repeats only (p,0.001; Figure
S3). Hence, targeted expression of i(CUG)480 RNA to the MBs
sensitizes flies to the genetic dose of mbl supporting that the
expression of CUG RNA in neurons reproduces a pivotal aspect of
the DM1 pathogenesis, namely partial loss of mbl function.
Chemical modifiers of a CUG-induced neuronal
phenotype
At 28uC the semilethal phenotype of 103Y-Gal4.UAS-(CTG)480
flies was highly sensitive to small changes in expression of CUG
RNA and was easy to quantify. It therefore provided a tool to
screen chemical suppressors of the neuronal toxicity to CUG
RNA. To this end, we assayed the ability of 400 compounds from
the Prestwick Chemical Library (PCL), a collection of drugs
selected for their biological activity, to increase viability of female
flies expressing i(CUG)480 RNA in their MBs.
Drugs were tested individually diluted in nutritive media to
<5 mM, which carried along the maximum amount of Dimethyl
Sulfoxide (DMSO) that flies could tolerate (Figure S4), and the
number of adult females was compared to controls (Figure 5J).
Statistical analysis identified ten molecules (p,0.01; 2.5% of
total tested) that significantly suppressed CUG-induced lethality
(Table S1).
Chemical suppressors were classified into five categories
according to their mechanism of action (MOA), including non-
steroidal anti-inflammatory agents, and drugs showing activity on
sodium and calcium metabolism (Table 2). Dopaminergic and
cholinergic neurons enervate motor neurons, which are among the
most abundant neuron populations in the Drosophila MBs [30],
[31]. Two classes of compounds identified specifically acted on
dopaminergic and cholinergic neurons, which suggests that
i(CUG)480 RNA is toxic to these cell types. Genetic evidence
supports this hypothesis; targeted expression of i(CUG)480 RNA to
dopaminergic (Ddc-Gal4) and cholinergic (Cha-Gal4) neurons
caused lethality (data not shown). Significantly, sodium channel
blocker clenbuterol, which has been suggested effective to treat
membrane excitability disorders including myotonic syndromes
[32], [33], improved viability.
Compounds inhibiting Gal4 activity would lower transgene
expression thus reducing toxicity to CUG RNA. Similarly, drugs
might be working by stabilizing or degrading the CUG repeat RNA.
To address these issues we first drove expression of the reporterUAS-
lacZ with the 103Y-Gal4 line andmeasured ß-galactosidase activity in
flies taking suppressor drugs and controls (Table S1). None of the
chemical suppressors tested significantly altered reporter expression.
Second, we measured the level of expression of 480 interrupted
CUG repeat RNA under the same conditions used for the chemical
screen in flies taking suppressor compounds and controls taking
DMSO. Levels of expression were comparable for all tested drugs
Figure 5. Dominant genetic enhancers and chemical suppressors of CUG-induced phenotypes. Stereomicroscope (A, B) and SEM (C–H)
views of adult Drosophila eyes. Female flies with the genotype sev-Gal4 UAS-i(CTG)480/+ (A, C, E) show eyes smaller than normal and externally rough.
Both features increased in female flies heterozygous for svp1 (B), Aly02267 (D), thread4 (F) and vikingk00236 (H) in the same genetic background whereas
overexpression of th (thEP3308, G) considerably improved morphology. Flies were raised at 25uC. (I) Percentage of viable females from crosses between
the X-linked 103Y-Gal4 line and lines carrying the UAS-i(CTG)480 or UAS-(CTG)60 transgenes (note that only F1 females express CUG RNA) at different
temperatures. Only expression of 480 CUG RNA exhibited a temperature-dependent semilethal phenotype. Three independent MB-specific Gal4
driver lines showed a similar behaviour. (J) Emerged/non-emerged ratio measures the likelihood of survival of CUG-expressing females in control
(2drug) and drug-treated flies (+drug). Abbreviations: 1, spironolactone; 2, metoclopramide; 3, ketoprofen; 4, nefopam; 5, orphenadrine; 6,
proglumide; 7, ethisterone; 8, indomethacin; 9, clenbuterol; 10, thioguanosine.
doi:10.1371/journal.pone.0001595.g005
Toxicity Model in Drosophila
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(Figure S1B). Taken together these results suggest that candidate
drugs did not significantly alter expression or stability of CUG repeat
RNA and thus act through alternative mechanisms.
Discussion
Drosophila flies expressing 162 pure CTG repeats in the context of
a 39UTR reporter gene show no detectable pathological phenotype
despite forming discrete ribonuclear foci in muscle cells [4]. This
suggests that ribonuclear foci are not directly pathogenic but also
that Drosophila might be refractory to CUG-induced toxicity since
162 pure CTG repeats are well within the pathogenic range in
humans. In an attempt to express larger CTG repeat expansions, we
and others [5] used synthetic, interrupted, CTG repeat minigenes
[34] to model DM1 in flies. This was necessary because
manipulation of large CTG repeat expansions is difficult due to
their intrinsic instability and failure to amplify by PCR. Interrupted
minigenes have been shown to reproduce molecular alterations
characteristic of DM1, in particular missplicing of cardiac troponin T
[34] and colocalization with Muscleblind in the cell nucleus ([35],
[5]; this work). In the fly, targeted expression of 480 interrupted
CTGminigenes to the eye precursors generated phenotypes sensitive
to the genetic dose of muscleblind and in the adult musculature
produced muscle degeneration ([5], this work). Furthermore, we
describe missplicing of muscle transcripts (CG30084 and troponin T).
Although these are all alterations consistent with interrupted CTG
repeats reproducing the behavior of pure CTG repeats, it remains
formally possible that interrupting CTCGA repeats initiate
molecular alterations unrelated to those of pure CUG repeat
RNA, or somehow modify CUG-dependent toxicity. In this regard
recent evidence shows that CGG trinucleotide repeats in permuta-
tion alleles of the fragile6gene (FMR1) cause neurodegeneration in
Drosophila [36], [37] and involve disruption of RNA-binding protein
function (hnRNP A2, Pura and CUG-BP1) as similarly described for
alternative splicing regulators Muscleblind and CUG-BP1 in DM1.
Thus, trinucleotide repeats similar to CTG have the capacity to
cause RNA gain of function effects through mechanisms distinct
from those described for CTG repeats.
DM1 was the first example of spliceopathy, i.e. expression of
splice products that are developmentally inappropriate for a
particular tissue. CUG repeat RNA effectively misregulated
alternative splicing of Z-band component CG30084 in Drosophila,
leading to a strong increase of a transcript isoform we detect as
RT-PCR band E (Figure 4A), whereas such isoform was almost
absent in control adult flies. Similarly, expression of a Drosophila
TnT transcript isoform we detect as RT-PCR band D (Figure 4B)
was repressed in pupae expressing CUG repeat RNA, also leading
to a developmentally abnormal alternative splicing. Expression of
60 CUG repeats altered alternative splicing of CG30084 and TnT
transcripts although these repeats did not appreciably affect
muscle morphology and did not accumulate in ribonuclear foci.
The apparent mismatch between molecular and cellular markers
of pathology merits further consideration. First, we detect a mild
eye phenotype in flies expressing 60 CUG repeats (Figure 3E) thus
suggesting that 60 CTG repeats are indeed toxic to Drosophila cells
but the phenotypes may be too weak to detect. Second, because
the role of the ribonuclear foci in the disease state is currently
unclear (foci are not pathogenic per se, at least in Drosophila [4]),
absence of foci is not evidence that 60 CTG repeats are not toxic
to Drosophila cells. Finally, the relevance of the alternative splicing
alterations we detect in the TnT and CG30084 genes is currently
unknown. However, we do note that all normal alternative splicing
products are detected in CG30084 and appearance of band D is
only delayed in TnT splicing. Therefore, we suggest that the
apparent lack of match between phenotype and molecular defects
in flies expressing 60 CUG repeat RNA might stem from the very
different sensitivities of molecular methods and standard pheno-
typic assessment methods. Expectation was that flies expressing
toxic RNA would show splice abnormalities typical of mbl loss-of-
function [10]. However, we can not verify this prediction because
no loss of mbl function phenotypes have been described in pupae
and adults so far. We do notice, nevertheless, that expression of
CUG repeat RNA in Drosophila embryos does not mimic molecular
alterations described for mbl mutants [11], but we found
inconsistencies in such description (Figure S2). It is also likely that
sequestration of Mbl by CUG RNA is incomplete, thus not
generating a mbl null-like molecular phenotype. Indeed, the
splicing of CG30084 was unaffected in mbl heterozygous embryos
[11] demonstrating that even a reduction of 50% in Mbl protein is
insufficient to interfere with splicing of CG30084.
Splicing of defined pre-mRNAs is defective in DM1, but the
cellular readout of those changes is only beginning to be
understood. The isolation of genetic enhancers and suppressors
of a CUG-induced phenotype provides an unbiased approach for
their identification. Our genetic screen recovered transcription
and chromatin remodelling factors as modifiers. Previous
observations have linked CUG toxicity to altered gene transcrip-
tion [38]. Weakened cell adhesion due to impaired basement
membrane, cell adhesion receptors, or both, might explain
detachment of subretinal cells and sensitivity to the genetic dose
of basement membrane component vkg and genes also influencing
cell adhesion and cytoskeleton dynamics such as cnc [23], coro [25],
and foi [26]. CUG repeat RNA might impair cell adhesion and
sensitize cells to programmed cell death thus accounting for the
reduction in eye size, and interaction with pro-apoptotic spin and
apoptosis inhibitor th. Cell loss has been reported in specific brain
areas of DM1 patients [1]. Cultured DM1 lens cells also show
increased cell death, although the triggering event appears to be
high intracellular Ca2+ levels [39]. Isolation of mutations in
mRNA export factor Aly as enhancers, finally, possibly under-
scores the relevance of changes in nuclear accumulation of
(CUG)480 transcripts for toxicity.
Table 2. Chemical suppressors of a CUG-induced semilethal
phenotype
Biological Activity Drug
Non-steroidal anti-inflammatory agents Ketoprofen*
Indomethacin*
Activity on dopamine receptors and
monoamine uptake inhibitors
Nefopam hydrochloride**
Metoclopramide monohydrochloride**
Muscarinic, cholinergic and histamine
receptors inhibitors
Orphenadrine dydrochloride**
Proglumide**
Activity on Na+ and Ca+2 metabolism Clenbuterol hydrochloride**
Spironolactone*
Other activities Thioguanosine*
Ethisterone**
*indicates p-value,0.01
**indicates p-value,,0.001
Chemical suppressors of a CUG toxicity phenotype in pupal brain. Chemical
suppressors were sorted by primary pharmacological activity. Assignments are
based on different online sources, mostly PubChem and DrugBank databases.
doi:10.1371/journal.pone.0001595.t002
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Out of 400 drugs tested we identified ten that notably alleviated
neuronal toxicity to CUG RNA. Assuming that the known MOA
of the suppressor drugs apply to Drosophila, we found a number of
molecules that inhibit neuron excitation through distinct mecha-
nisms. These include dopamine D2 receptor antagonists (meto-
clopramide), inhibitors of monoamine reuptake (nefopam), and
muscarinic and histamine receptor blockers (orphenadrine).
Mutations that decrease or increase membrane excitability are
known to trigger neurodegeneration to varying degrees in
Drosophila [40]. Expanded CUG repeats might similarly induce
excitotoxicity to MB neurons. Alternatively, neuronal hyperactiva-
tion may affect motor neurons in the brain, because pupae failed
to emerge but were viable if released from puparium manually.
Using our CUG RNA fly model we identified mutations and
drugs that significantly modified CUG toxicity phenotypes. These
results advance our understanding of the cellular processes altered
by CUG RNAs and provide a proof-of-concept data that Drosophila
DM1 models can be successfully utilized for chemical screens.
Materials and Methods
Drosophila transgenics
Construct UAS-(CTG)60 was generated by subcloning 54
uninterrupted CTG repeats from the pCTG54 plasmid [41] into
the EcoRI/BamHI sites of the Drosophila expression vector pUAST.
Sequencing of the construct revealed that repeats expanded to 60
during cloning. Because DM1 alleles carrying longer expansions
probed intractable we decided to use synthetic CTG repeats
interrupted every 20 CTG units by the sequence CTCGA [34].
CTG repeats in sp72 (Promega) were digested with XhoI and
cloned into the same site in pUAST to generate the UAS-i(CTG)480
construct. Both transgenes were injected into y1w1118 embryos and
independent lines established (6 UAS-(CTG)60 and 14 UAS-
i(CTG)480). Nine out of 14 UAS-i(CTG)480 lines were crossed to
T80-Gal4, sev-Gal4, gmr-Gal4 and Mhc-Gal4 (see below for a
description of these drivers) at different temperatures of culture. Of
these, seven (1.1, 2.2, 3.3, 6.4, 7.1, 9.2, 13.1) revealed externally
similar phenotypes in eyes, thorax/wing positioning, or ability to
fly. Subsequent experiments were carried out with transgenic line
1.1, except for the assessment of nuclear CUG repeat RNA foci
formation, which was also performed with transgenic line 2.2
giving the same qualitative result. Transgenic flies UAS-mblC:GFP
will be described elsewhere. Briefly, the coding region of mblC was
amplified by PCR and cloned in frame with GFP into peGFP-N3
(Clontech). The entire fusion gene was excised with BglII/NotI and
subcloned into pUAST digested with the same enzymes.
Transgenic flies were generated as above.
Fly strains and crosses
Mhc-Gal4 was obtained from G. Davis [42]; gmr-Gal4 from A.
Ferru´s (Instituto Cajal, Madrid); sev-Gal4 from M. Mlodzik (Mount
Sinai School of Medicine, New York); 103Y-Gal4 from J.D.
Armstrong [43] and Ddc-Gal4 from Mel Feany [44]. All other
strains were from the Bloomington Drosophila Stock Center
(Indiana) except for our own mbl mutant stocks and UAS-MBNL1
flies [45]. mbl7103 is a P{lacW} insertion approximately 57 bp
upstream of the mblA mRNA start site [46]. mblE27 is an imprecise
excision from P{lacW} insertion mbl05507b that removes exons 1
and 2 [47]. Females of the genotype y1w1118; UAS-i(CTG)4801.1 sev-
Gal4/TM3 were crossed to males from a collection of 695 P{lacW}
lethal insertions on the 2nd and 3rd chromosomes [48]. To produce
the genotypes shown in Figure 2A y1w1118; UAS-i(CTG)480 1.1
females were crossed to y1w1118; hs-Gal4/CyO y+; UAS-mblC:GFP/+
males and adult offspring, in plastic vials, were heat shocked at
37uC for 1 h.
Scanning electron microscopy (SEM) and histology
Adult Drosophila eyes and thoraces were dissected out and
embedded in Epon for transversal semi-thin sectioning [49] or
processed for SEM [50]. Alternatively, thoraces were embedded in
OCT and transversal sections (12 mm) were taken with a Leica
CM 1510S cryomicrotome. Sections were processed for in situ
hybridization with a Cy3-labeled (CAG)10 probe and fluorescent
detection of the MblC:GFP fusion protein as described [4]. SEM
images were from a HITACHI S-2500. Image Manager Leica
IM50 software was used to acquire cross-sectional muscle and
vacuole areas.
Reverse transcription-polymerase chain reaction (RT-PCR)
assay
Total RNA was extracted using Tri-Reagent (Sigma). To
analyze the splicing patterns, 5 mg of total RNA were treated with
DNase I and reverse transcribed (RT) with SuperScriptII RNase
H2 RT following instructions from the provider (Invitrogen).
10 ml of a 1:25 dilution (CG30084), 1 ml (Drosophila TnT) or 1 ml of
a 1:100 dilution (Rp49) of the RT reaction were used as template
in a standard 50 ml (CG30084) or 20 ml (TnT, Rp49) PCR using
TaKaRa LA Taq (CG30084) or Thermus thermophilus DNA
polymerase (Netzyme, NEED) (TnT, Rp49) polymerases. For
cycling conditions, primer sequences and annealing temperatures
see supplementary materials and methods (Text S1) and Table S2.
Compound administration and screen
Laying pots from en masse crosses (yw; +; UAS-
i(CTG)4801.16103Y-Gal4/Y; +; +) were periodically checked for
first instar larvae. Ten male larvae of the genotype yw/Y; +; UAS-
i(CTG)480/+ and 20 female larvae with the genotype yw/103Y-
Gal4; +; UAS-i(CTG)480/+ were hand-picked and transferred to
vials with 1 ml of Instant Drosophila Medium (SIGMA) containing
5 mM of compound or 0.1% DMSO in controls. 400 compounds
of the PCL (Tables S3 and S4) were individually tested in
triplicate. Cultures were grown at 28uC and the sex of adults
scored. Males were used as internal controls to discard unviable
cultures or toxic drugs. Compounds showing activity in the initial
screen (p,0.01; 30 drugs) were independently tested two more
times in triplicate as above. For ß-galactosidase activity readings
and DMSO toxicity assays see supporting materials and methods.
Statistical analysis
For the chemical screen, the following modification of the
Fisher’s exact test (a=0.01) was used to analyze data from small
size samples:
P~
Xaz1
i~1
Pi~
Xaz1
i~1
(azb)!(czd)!(azc)!(bzd)!
(az1{i)!(b{1zi)!(c{1zi)!(dz1{i)!n!
where a is emerged females from control; b is dead females from
control; c is emerged females form drug treated culture; d is dead
females from drug treated culture. The number of emerged and
dead females after drug administration was compared to that in
control cultures. Data from all replicates was summed up and
treated all together in order to increase the power of the test giving
a final n= 60 (initial screen), or 180 for those drugs that were re-
tested. We note that because the test we developed is exact,
meaning by that we know the probability of the first species error
and the potency of the test, the number of false positives does not
increase with the continued use of the test. A t-student test was
applied to all other comparisons between two groups.
Toxicity Model in Drosophila
PLoS ONE | www.plosone.org 8 February 2008 | Volume 3 | Issue 2 | e1595
Supporting Information
Text S1 It contains supplementary material and methods and
supplementary reference list
Found at: doi:10.1371/journal.pone.0001595.s001 (0.04 MB
DOC)
Figure S1 Levels of transgene expression. RT-PCR detection of
CUG repeat RNA from UAS-(CTG)60 and UAS-i(CTG)480
transgenes (A) and from UAS-i(CTG)480 (B), driven by the
indicated Gal4 line, in the presence of DMSO (control, 1),
spirolonactone (2), clenbuterol (3), metoclopramide (4), ethisterone
(5), orphenadrine (6), thioguanosine (7), and ketoprofen (8) at the
same concentrations used in the chemical screen. RNA from yw
flies was used as negative control and Rp49 transcripts were
amplified as control of input RNA. (A) Levels of expression from
both the UAS-(CTG)60 and UAS-i(CTG)480 transgenes were
equivalent both in pupae (P) and adult flies (A).
Found at: doi:10.1371/journal.pone.0001595.s002 (4.24 MB TIF)
Figure S2 Genomic organization of CG30084 and alternative
splicing isoforms detected. Exon usage in RT-PCR bands A to D
(embryonic) and E (adult) according to the nomenclature used in
Figure 3A. Bands A to D correspond to bands a to d in [11].
According to our results exon 12b is not detected in any RT-PCR
product and exon composition of all bands shows inconsistencies
with the published description [11].
Found at: doi:10.1371/journal.pone.0001595.s003 (0.37 MB TIF)
Figure S3 CUG repeat RNA interferes with Muscleblind function
in the brain structures the mushroom bodies. Expression of
expanded CUG repeat RNA in the mushroom bodies of female
flies is detrimental as only 32 individuals out of 214 were female in
contrast with the expected 107 (second column; O/E ratio of 0.3).
Flies heterozygous for mbl mutant allele mblE27 that simultaneously
express CUG repeat RNA in their MBs show a further six fold
reduction in viable female flies. 5 flies of the genotype of interest out
of 368 were observed versus an expected number of 92 (O/E ratio of
0.05). Note that the presence of the transgene alone does not affect
survival as the O/E ratio in males is still 1. These results show that
muscleblind function is compromised in CUG-expressing MB
neurons, thereby confirming the relevance of this phenotype to
study DM1 defects in the brain. *** indicates p-value ,,0.0001.
Found at: doi:10.1371/journal.pone.0001595.s004 (0.72 MB TIF)
Figure S4 Toxicity of DMSO carrier. yw larvae were fed food
containing increasing concentrations of DMSO and the number of
individuals that reached adulthood was scored. Ten larvae were
tested per replicate and up to five replicates were analyzed for each
concentration. DMSO was not toxic up to 0.1% whereas
concentrations of 0.15% or higher reduced viability in a dose-
responsive manner when compared to controls; *** indicates p-
value ,, 0.001. Bars represent standard deviations.
Found at: doi:10.1371/journal.pone.0001595.s005 (0.04 MB TIF)
Table S1 Complete list of chemical suppressors of a CUG-
dependent semilethal phenotype. Drugs are listed alphabetically
along with their main known activity in human cells, effect on
expression of the UAS-lacZ reporter (measured by the enzymatic
activity of b-galactosidase), and chemical structure. b-galactosidase
activity comparisons between drug-treated flies and controls were
only performed when total protein quantifications found no
significant differences between samples.
Found at: doi:10.1371/journal.pone.0001595.s006 (0.08 MB
DOC)
Table S2 Names, sequences and annealing temperatures of
primers used in this work.
Found at: doi:10.1371/journal.pone.0001595.s007 (0.04 MB
DOC)
Table S3 Complete listing of drugs assayed in this study
Found at: doi:10.1371/journal.pone.0001595.s008 (0.04 MB
XLS)
Table S4 Primary data from the chemical screen. For each
compound we show in columns the number of females that
emerged/not emerged in drug treated and control cultures as well
as the p-value of the statistical analysis. Rows contain the results
from each replicate, with triplicates from independent experiments
highlighted with the same colour.
Found at: doi:10.1371/journal.pone.0001595.s009 (0.06 MB
XLS)
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